News | Contrast Media Injectors | May 03, 2016

GlobalData says near doubling will be driven by increases in CT/MR/angiography procedures

GlobalData, contrast media injectors market,

May 3, 2016 — The global market for contrast media injectors is set to increase from $830 million in 2015 to almost $1.8 billion by 2022, according to research and consulting firm GlobalData. This represents a compound annual growth rate (CAGR) of 11 percent.

The company’s latest report states that this rise, which will occur across 15 major markets, will mainly be driven by increases in the number of annual computed tomography (CT), magnetic resonance imaging (MRI) and angiography procedures, as well as growth in the utilization of contrast media injectors and increasing disease burdens.

Sarah Janer, GlobalData’s analyst covering medical devices, explained, “Contrast injectors can only be used alongside imaging devices, so the contrast media injector market relies on the growing demand for MRI and CT scanners. Indeed, as MRI machines are not normally packaged with an injector, hospitals must purchase MRI injectors separately from the suppliers.

“CT contrast injectors, on the other hand, are usually packaged with CT scanner sales, so although the market for both types of injectors is growing, CT contrast media injectors experience higher replacement rates than new sales.”

The CT segment is the largest and fastest growing in the market and will rise at a CAGR of 12.3 percent during the forecast period, thanks to the rising popularity of CT imaging systems, which have become a standard for diagnostic imaging around the world. Single-head injectors make up the majority of the market’s volume due to their low average selling price, which makes them especially attractive in emerging economies and hospitals that are pressed for funding.

However, Janer noted, “With the decline of CT injector prices in all sub-sections and geographies, GlobalData expects that dual-head injectors will experience high growth as hospitals seek to upgrade their injectors with more efficient models for lower costs.”

For more information: www.globaldata.com

Related Content

News | Contrast Media Injectors

September 16, 2021 — FDB (First Databank), a leading provider of drug and medical device knowledge that helps healthcare ...

Time September 16, 2021
arrow
News | Contrast Media

Chemical substances that improve the visibility of specific organs, tissues, or blood vessels during a diagnostic or ...

Time May 03, 2021
arrow
News | Contrast Media Injectors

February 25, 2021 — Guerbet announced the launch of OptiProtect 3S, a new range of technical services for its injection ...

Time February 25, 2021
arrow
Sponsored Content | Case Study | Contrast Media Injectors

Steinberg Diagnostic Medical Imaging (SDMI) was founded 30 years ago and has grown to be one of the largest outpatient ...

Time January 21, 2021
arrow
Feature | Contrast Media Injectors | By Melinda Taschetta-Millane

According to a new research report1 on the contrast media injectors published by MarketsandMarkets, the market was ...

Time January 20, 2021
arrow
News | Contrast Media

December 28, 2020 — Adding a contrast-enhancing agent to magnetic resonance imaging (MRI) significantly improves image ...

Time December 28, 2020
arrow
News | Contrast Media

November 26, 2020 — GE Healthcare has received U.S. FDA approval of its macrocyclic gadolinium-based MRI contrast agent ...

Time November 26, 2020
arrow
News | Contrast Media Injectors

November 17, 2020 — Bracco Diagnostics Inc. announced it will be showcasing its full portfolio of diagnostic imaging ...

Time November 17, 2020
arrow
News | Contrast Media

November 17, 2020 — Guerbet announced that it will highlight UNIK, a tailored solution for diagnostic imaging, at the ...

Time November 17, 2020
arrow
News | Contrast Media Injectors

September 2, 2020 — According to the new market research report "Contrast Media Injectors Market By Product (Injector ...

Time September 02, 2020
arrow
Subscribe Now